Kaiser Robert A, Bueno Orlando F, Lips Daniel J, Doevendans Pieter A, Jones Fred, Kimball Thomas F, Molkentin Jeffery D
Department of Pediatrics, University of Cincinnati, Children's Hospital Medical Center, Division of Molecular Cardiovascular Biology, Cincinnati, Ohio 45229-3039, USA.
J Biol Chem. 2004 Apr 9;279(15):15524-30. doi: 10.1074/jbc.M313717200. Epub 2004 Jan 28.
The p38 branch of the mitogen-activated protein kinase (MAPK) signaling cascade has been implicated as a regulator of cardiomyocyte apoptosis in culture as well as in the adult heart. However, considerable disagreement persists as to the functional effects attributed to p38 signaling, given that both pro- and anti-apoptotic regulatory roles have been reported. To address this area of uncertainty in the literature, we investigated the cell death effects associated with p38 inactivation in both cultured neonatal cardiomyocytes and the adult heart. In vitro, adenoviral-mediated gene transfer of two different dominant-negative-encoding p38 vectors reduced apoptosis induced by 2-deoxyglucose treatment, whereas overexpression of wild-type p38alpha or an activated mitogen-activated protein kinase kinase (MKK)6 mutant each enhanced cell death. In vivo, transgenic mice expressing a dominant-negative MKK6 mutant or a dominant-negative p38alpha mutant were each significantly protected from ischemia-reperfusion injury, as assessed by infarct area measurements, DNA laddering, terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling, and functional assessment of ventricular performance. Similarly, transgenic mice overexpressing the p38-inactivating dual specificity phosphatase MAPK phosphatase-1 (MKP-1) were also partially protected, whereas MKP-1 gene-targeted mice showed greater injury after ischemia-reperfusion injury. Mechanistically, inhibition of p38 signaling promoted a dramatic up-regulation of Bcl-2 in the hearts of transgenic mice. In primary neonatal cardiomyocyte cultures, adenoviral-mediated gene transfer of a p38 inhibitory mutant up-regulated Bcl-2, whereas expression of an activated p38 mutant down-regulated Bcl-2 protein levels. Collectively, these results indicate that p38 functions as a pro-death signaling effector in both cultured myocytes as well as in the intact heart.
丝裂原活化蛋白激酶(MAPK)信号级联反应的p38分支,在体外培养的心肌细胞以及成年心脏中,被认为是心肌细胞凋亡的调节因子。然而,鉴于p38信号传导既有促凋亡作用又有抗凋亡调节作用的报道,对于其功能效应仍存在相当大的分歧。为了解决文献中这一不确定的领域,我们研究了在体外培养的新生心肌细胞和成年心脏中,与p38失活相关的细胞死亡效应。在体外,两种不同的显性负性编码p38载体的腺病毒介导的基因转移减少了2-脱氧葡萄糖处理诱导的细胞凋亡,而野生型p38α或活化的丝裂原活化蛋白激酶激酶(MKK)6突变体的过表达均增强了细胞死亡。在体内,通过梗死面积测量、DNA梯状条带分析、末端脱氧核苷酸转移酶介导的dUTP缺口末端标记以及心室功能的功能评估,表达显性负性MKK6突变体或显性负性p38α突变体的转基因小鼠均显著免受缺血再灌注损伤。同样,过表达p38失活双特异性磷酸酶MAPK磷酸酶-1(MKP-1)的转基因小鼠也受到部分保护,而MKP-1基因敲除小鼠在缺血再灌注损伤后表现出更严重的损伤。从机制上讲,p38信号传导的抑制促进了转基因小鼠心脏中Bcl-2的显著上调。在原代新生心肌细胞培养中,p38抑制突变体的腺病毒介导的基因转移上调了Bcl-2,而活化的p38突变体的表达下调了Bcl-2蛋白水平。总的来说,这些结果表明p38在体外培养的心肌细胞以及完整心脏中均作为促死亡信号效应器发挥作用。